Cholangitis primary prevention: Difference between revisions
Jump to navigation
Jump to search
Line 12: | Line 12: | ||
*Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages.<ref name="pmid7986900">{{cite journal |vauthors=van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ |title=Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis |journal=Clin. Infect. Dis. |volume=19 |issue=2 |pages=279–86 |year=1994 |pmid=7986900 |doi= |url=}}</ref> | *Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages.<ref name="pmid7986900">{{cite journal |vauthors=van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ |title=Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis |journal=Clin. Infect. Dis. |volume=19 |issue=2 |pages=279–86 |year=1994 |pmid=7986900 |doi= |url=}}</ref> | ||
**A metal or plastic [[stent]] within the bile system may be needed to prevent recurrence | **A metal or plastic [[stent]] within the bile system after the procedures involving drainage of the biliary tree, may be needed to prevent recurrence.<ref name="pmid34544">{{cite journal |vauthors=Butler SJ, Landon M |title=Transglutaminase-catalysed labelling of cytochrome c and cytochrome c oxidase [proceedings] |journal=Biochem. Soc. Trans. |volume=7 |issue=2 |pages=397–8 |year=1979 |pmid=34544 |doi= |url=}}</ref> | ||
==References== | ==References== |
Revision as of 21:07, 15 December 2017
Cholangitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cholangitis primary prevention On the Web |
American Roentgen Ray Society Images of Cholangitis primary prevention |
Risk calculators and risk factors for Cholangitis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farwa Haideri [2]
Overview
Although reestablishing biliary drainage is the main focus of treatment, antibiotics play an important role in the management of cholangitis.
Primary Prevention
- There are no established measures for the primary prevention of cholangitis in otherwise healthy people.
- Treatment of gallstones, tumors, and infestations of parasites may reduce the risk for some people.
- Patients undergoing ERCP should have prophylactic antibiotics.
- Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages.[1]
References
- ↑ van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ (1994). "Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis". Clin. Infect. Dis. 19 (2): 279–86. PMID 7986900.
- ↑ Butler SJ, Landon M (1979). "Transglutaminase-catalysed labelling of cytochrome c and cytochrome c oxidase [proceedings]". Biochem. Soc. Trans. 7 (2): 397–8. PMID 34544.